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Neurons that utilize dopamine (DA) as a neurotransmitter have attracted great interest because of their involvement in the behav-
ioral, endocrine and descending control of major brain functions. DA is known to exert its physiological effects on target neurons 
through D1-like (D1 and D5) and D2-like (D2, D3 and D4) receptor subtypes. To better understand the DA modulation of brain 
functions, the distribution and cellular localization of D1 and D2 DA receptors in the rat forebrain is reviewed, and their possible 
role in cognitive aspects of behavior is discussed. In general, DA receptors are differentially expressed and mostly distributed in 
different target fields of DA neurons. Both D1 and D2 receptor gene products are found in the cerebral cortex, basal ganglia and
hippocampal formation, albeit in different cell groups or neuronal subpopulations, whereas D3 receptors are mainly located in 
limbic regions. In the cortex, mRNA signals are seen in all the areas and cortical layers except layer I. In the striatum, the most 
intense signal is found in the caudate-putamen, nucleus accumbens and olfactory tubercle where a large number of cells are 
strongly labeled for D1 and D2. In the globus pallidus only scattered D2 mRNA-containing cells are present. In contrast, no D1 
or D2 messages can be seen in the ventral pallidum. In the basal forebrain, mRNA encoding the D1 receptor is detected in the 
islands of Calleja. The medial and lateral septal nuclei show a low D2 signal. In the amygdaloid nuclear complex, the strongest 
D1 receptor message is observed in the basomedial and basolateral nuclei. Conversely, the highest density of D2 mRNA-express-
ing cells is revealed in the central nucleus. Moderately labeled for D1 and D2 cells are scattered throughout the anterior and 
posterior subdivisions of the bed nucleus of stria terminalis, and within all subfields of the hippocampal formation and dentate
granule cell layer. Differential regional and cellular distribution of DA receptors in the forebrain provides anatomical evidence 
for an area-specific regulation of the DAergic neurotransmission. It can be inferred that DA facilitates learning, memory and
cognition processes via activation of both the D1 and D2 receptors. Biomed Rev 2005; 16: 59-75.
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INTRODUCTION
Dopamine (DA) acts as a key neurotransmitter in the brain. 
It has been proposed that it may play an important role in the 
pathophysiology of a variety of psychiatric and neurological 
disorders. This is particularly true for schizophrenia, 
Alzheimer's, Huntington’s  and Parkinson’s diseases, where 
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DA involvement in the neostriatal, mesolimbic, mesocortical 
or nigrostriatal systems has been well acknowledged (1-5). It 
is thus noteworthy that DA is thought to be included in the 
regulation of motor, limbic and cognitive aspects of behavior. 
Besides, neurons that utilize DA as a neurotransmitter 
constitute a focus of neuroscience research because of their 
involvement in the behavioral flexibility, neuroendocrine
and descending control of brain functions (6). This variety 
of DA functions is partly related to the variable distribution 
of DAergic fibers and terminals in most regions of the brain,
and also to the multitude of receptors mediating different 
types of effects in response to DA (7,8). Although numerous 
studies over the last 30 years provide some important clues 
for understanding the molecular mechanisms by which DA 
regulates neural functions, its receptor signaling has not been 
fully elucidated and is still a matter of ongoing discussion. 
 The diverse physiological effects of DA are mediated by 
at least five G protein-coupled receptor subtypes encoded
by different genes referred to as D1-D5 (reviewed in 9-13). 
On the basis of the amino acid sequences and structural and 
pharmacological similarities, these have been grouped into 
D1-like (D1 and D5) and D2-like (D2short, D2long, D3 and 
D4) subfamilies (for reviews see 14-16). Like other receptor 
proteins, DA receptors are located at the cell membrane, where 
they interact with DA, regulate specific intracellular signaling
networks, and modulate the cellular functions. However, the 
activation of D1-class or D2-class receptors has different 
effects on signal transduction pathways. In particular, a 
differential mode of coupling to adenylate cyclase is observed: 
D1 receptor stimulation elevates cyclic AMP concentration 
while D2 receptor activation decreases it (15-18). In addition, 
D1 receptor activation by agonists induces stimulation of both 
cyclic AMP-dependent protein kinase A (PKA) and protein 
kinase C (PKC), while D2 receptor stimulation can activate 
PKC (15). Therefore, the study of DA receptors has been a 
primary approach in revealing the physiological roles of the 
DA systems. A further important step toward understanding 
the specific functions of various DA receptor subtypes is to
delineate their corresponding post-receptor targets (19).
 The anatomical distribution of the DA receptors provides 
an interesting basis for speculating on the functional role 
of their different subsets. Thus far, the principal receptor 
subtypes (D1 and D2) have been visualized in the rat brain 
using receptor autoradiography with selective ligands (20-23) 
and immunohistochemistry with subtype-specific antibodies
(24-27). In addition, in situ hybridization (ISH) histochemistry, 
both radioactive and non-radioactive, has revealed a 
widespread distribution of their corresponding mRNAs in the 
rat brain (23,28-35). These studies demonstrate that D1-like 
are more abundant than D2-like receptors. However, the latter 
are major targets for action of antipsychotic drugs (27,36). 
Previous investigations have also established the presence of 
the two major DA receptor subtypes, the D1 and D2 receptor, 
in the rat forebrain, including the cerebral cortex (37) and basal 
ganglia (38-40), but have not provided detailed distributional 
patterns of dopaminoceptive neurons in all forebrain regions 
at the cellular level. Moreover, many of these results are 
conflicting.
 In the past years, it became apparent that D1 and D2 
receptor genes are expressed in distinct neuronal populations 
in the rat forebrain. Such evidence has principally come from 
studies on the striatum (41). On the other hand, critiques of 
this speculation have also been published (see 42 and refs. 
therein). Although a general consensus has developed about 
many aspects, there are still inconsistencies and controversies, 
usually related to which cell types express given receptors 
and whether a signal obtained reflects a functionally relevant
receptor (43). Last of all, complex functional interactions 
exist between the D1- and D2-like families, some of whose 
mechanisms are not clearly understood yet and remain 
uncertain. 
 The goal of this review article is therefore to develop a 
detailed map of the D1 and D2 receptor gene expression in the 
adult rat forebrain using non-radioactive ISH histochemistry, 
a procedure which allows a highly-resolved detection of 
positive neurons, and thus to provide an increasing knowledge 
of their regional localization. Another goal of our analysis is 
to compare the distribution of dopaminoceptive cells with 
the distribution of receptor binding sites and with that of the 
DAergic innervation patterns previously described. Finally, we 
aim at answering the question of direct involvement of DA in 
regulating cognition, memory and learning. In this respect, it 
should be emphasized that research in the field of the DAergic
system, a model for studying learning and memory in health 
and disease, was awarded the Nobel Prize in Physiology or 
Medicine in 2000.
ANATOMIC AND FUNCTIONAL ORGANIZATION OF THE 
DOPAMINERGIC SYSTEM
It is well known that DA exerts its actions through four 
different pathways. The nigrostriatal pathway originates in 
the substantia nigra pars compacta (A9) and projects to the 
striatum (44). It constitutes about 80% of the brain DAergic 
system. The mesolimbic and mesocortical DA neurons derive 
from the ventral tegmental area (A10). The former project 
to the nucleus accumbens, septal area, olfactory tubercle, 
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amygdaloid cortex and piriform cortices, while the latter 
reach the prefrontal, cingulate and entorhinal cortices (45). 
Conversely, the prefrontal cortex (the prelimbic area of the 
medial frontal cortex), which represents the second main target 
of ventral tegmental area dopamine neurons (37,46), receives 
distinct parallel DAergic inputs and its neurons project back 
to the cells of origin (47). Hypothalamic DAergic neurons 
project to the median eminence and infundibular stem, thus 
forming the tuberoinfundibular pathway, the functional role 
of which is to suppress prolactin excretion from the pituitary 
gland (48).
 Such an organization and prominent distribution of 
DAergic innervation throughout anatomically segregated 
neuronal systems that involve the integration of motor, 
limbic and cognitive processes as well as the tonic mode of 
functioning confer on the DAergic subsystems a key role 
in the coordination and integration of different aspects of 
behavior (49). It is generally believed that their dysregulation 
may result in neuropsychiatric disorders. Specifically, the
nigrostriatal system is related to motor functions (50), while 
the mesocorticolimbic DAergic system, innervating the 
ventral striatum, cortex and limbic areas, is a substrate for 
motivation and reward (for reviews see 50,51). In addition, the 
nucleus accumbens receiving projections from some limbic 
areas (hippocampus and amygdala) is thought to be related 
to “motivational” behavior (52,53). Recent studies implicate 
an important role for the prefrontal cortex in the selection 
and generation of behavior patterns (47). On the other hand, 
it is proposed that basal forebrain neurons belong to multiple 
systems with distinct cognitive, motivational, emotional, 
motor and regulatory functions (54). They can modulate the 
activity of neurons in the neocortex through their direct cortical 
projections and indirectly through their projections to the 
thalamus via the thalamocortical system. Lately, Previc (55) 
emphasized a putative essential contribution of cortical DA 
to executive function and also to language production, which 
critically involves working memory processes.
 A few smaller DA projecting systems are currently 
described as well: the mesohippocampal pathway, with an 
essential effect on the memory systems, and the projection of 
some nigral neurons to the frontal cortical areas (mesofrontal 
pathway), which is thought to be important in reward and 
motivation mechanisms.
DISTRIBUTION OF DOPAMINE AND DOPAMINE RECEPTORS 
IN THE RAT FOREBRAIN
General considerations
Numerous studies over the last decade have shown the cellular 
targets of DA innervation and occurrence of DA receptors 
throughout the forebrain in rodents, nonhuman primates and 
humans, although there is not yet a steady consensus on this 
issue in different species. As a rule, the mRNA hybridization 
signal is expressed by neurons. With the exception of 
ependymal cells, including the choroid plexus epithelium and 
tanycytes, glial cells are not distinctly labeled. The discussed 
brain structures onward comply with the rat brain stereotaxic 
atlas of Paxinos and Watson (56).
 By using non-radioactive ISH, we and others have 
demonstrated that mRNAs encoding D1 (mRNAD1) and 
D2 (mRNAD2) receptors have a widespread distribution in 
the adult rat forebrain (Table 1), much larger than hitherto 
believed (33,35,37,57-61). D1 and/or D2 receptor messages are 
expressed in all major forebrain areas receiving DA projections. 
Particularly, the strongest ISH signals are detected in the 
neostriatum, olfactory tubercle, and the nucleus accumbens. 
Furthermore, we found that both D1 and D2 receptor gene 
products can be detected in other DA target areas including 
the amygdala, albeit in different cell groups or neuronal 
subpopulations. Distinct D1 and D2 hybridization patterns 
are also evident in the bed nucleus of the stria terminalis 
and the septal nuclei. In addition, D1 or D2 messages have 
been visualized in regions where a DAergic innervation is 
controversial, such as some cerebral cortical areas and the 
hippocampal formation. The cells containing mRNAD1 and 
mRNAD2 are distributed throughout the rostrocaudal extent 
of the telencephalon as follows.
Cerebral cortex
The cerebral cortex is an important target of DAergic 
neurotransmission (31), as it can directly mediate some of the 
effects of DA on working memory (62-64). In monkeys and 
humans, DAergic terminals innervate the entire cortical areas in 
a rostrocaudal gradient (65), while in rodents they are restricted 
to the frontal lobe and particularly to the prefrontal, entorhinal 
and piriform cortices (66,67). Generally, mammalian cortical 
neurons express mRNA and protein of D1 and D5 receptors 
(31,68). In the human brain, the D1 expression dominates, 
with a low D2 expression in most neocortical regions (69). 
On the other hand, D4 receptor is the most abundant D2-like 
receptor in the rat cerebral cortex (27,70,71). However, the 
exact physiological action of DA on cortical cells is not yet 
elucidated as D1 and D2 receptor agonists have been shown 
to elicit both excitatory and inhibitory responses (72-74). 
In a previous paper we have shown that a D1 receptor gene 
transcript is seen in all cortical areas and layers except layer I 
(35). In the regions investigated, a laminar distribution of DA 
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Brain region DA innervation* D1 mRNA D2 mRNA
Cerebral cortex
Neocortex ++      ++     +/–
Anteromedial prefrontal cortex ++      ++     +
Suprarhinal prefrontal cortex ++      ++     +
Supragenual prefrontal cortex ++      +/–     –
Entorhinal cortex +      +++    +++
Perirhinal cortex +      ++     +
Piriform cortex +      +++    +++
Cingulate cortex +       +     –
Retrosplenial cortex +       +     –
Endopiriform nucleus +       +     –
Basal ganglia and basal forebrain
Caudate-putamen +++      +++    ++
Nucleus accumbens +++      +++    +++
Olfactory tubercle +++      +++     ++
Islands of Calleja ++       ++     +/–
Globus pallidus  +        –      +
Ventral pallidum  +        –      –
Substantia innominata  +        –      –
Magnocellular preoptic nucleus  +        +      –
Basal nucleus of Meynert  +        +      –
Diagonal band of Broca ++        –      –
Septum
Lateral septal nucleus ++      ++     +
Medial septal nucleus  –       –    +/–
Septohippocampal nucleus  –       –     –
Hippocampal formation
Ventral hippocampus 
   Subicular complex +/–      ++       –
   CA1, CA2, and CA3 fields +/–     +++       –
   of Ammon’s horn
   Dentate gyrus +/–      ++       –
Dorsal hippocampus
   Dentate granule cells +/–      ++       –
   CA1-CA3 pyramidal cells +/–      ++       –
Amygdaloid nuclear complex
Intercalated cell groups +++      ++      –
Basolateral amygdaloid nucleus  +     +++     +/–
Basomedial amygdaloid nucleus  +     +++     +/–
Cental amygdaloid nucleus  +++       +     +++
Cortical nucleus ++      ++       –
Bed nucleus of stria terminalis +++      ++       –
+++, high ISH signal; ++, moderate; +, weak; +/–, very weak; –, absent
*These data are based on Ref. 66,67,77,93,95,96,98,102,110.
Table 1. Comparison of DA innervation with DA receptor mRNA expression in the adult rat forebrain.
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Figure 1. Distribution and cellular localization of mRNAD1 and mRNAD2 in different regions of the rat cerebral cortex. (A) 
Piriform cortex (Pir), the olfactory tubercle (Tu) and the posteromedial cortical amygdaloid nucleus (PLCo). The most prominent 
signals are found in layers V and VI, and at the junction between the medial piriform cortex and cortical amygdaloid nucleus. (B) 
Perirhinal cortex (PRh). All the neurons in layers II, V and VI show an intense ISH signal. (C) Parietal cortex, area 2 (Par2). (D) 
Hindlimb area of the cortex (HL) and part of the hippocampus, showing high labeling of the pyramid cells of CA1. The details of 
neuronal labeling are shown at a higher magnification in (E). Note the strong hybridization signal in the cells of the pyramidal 
layer (arrows) and the much weaker signal in the other cortical layers. LV, lateral ventricle; VEn, ventral endopiriform nucleus. 
Scale bars = 170 µm in A-D; 30 µm in E.
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receptor messages is maintained, as illustrated in Fig. 1.
 In the paleocortex, most mRNAD1-expressing cells are 
observed in the piriform (Fig. 1A), perirhinal (Fig. 1B), 
entorhinal and cingulate cortex (not shown). Cells of the 
piriform cortex are prominently labeled, with higher levels 
in cortical layers II-III, V and upper layer VI. Moderate 
hybridization signals are obtained in the entorhinal cortex. D1 
message is also expressed in other allocortical regions, such as 
the perirhinal cortex. Neurons are moderately labeled in layers 
II, V and VI, while in the middle layers the signal is weaker. 
Additionally, modetare-to-low levels of mRNAD1 are observed 
in layers V-VI of the cingulated cortex. In the isocortex, higher 
signals are present in the deeper layers of the anteromedial 
and suprarhinal prefrontal cortex. An apparent decrease in the 
hybridization signal is registered in caudal direction. mRNAD1-
positive cells are also found in the endopiriform nucleus.
 On the other hand, D2 receptor gene transcript distribution 
in the rat cortical fields is topographically more restricted.
In addition, the cortical areas show a dissimilar distribution 
pattern of the mRNAD2 expression. In fact, the laminar 
distribution pattern of the ISH signal shows bands with 
labeling in both the superficial and deep layers. Specifically,
D2 receptor gene-expressing neurons are mainly located in 
the prefrontal cortex, almost exclusively in layer V. Within 
the paleocortical regions, entorhinal cortex (layers II-III), the 
most superficial cells of layer I and piriform cortex show a
high density of mRNAD2. 
 Regarding the neocortex, the great majority of neurons 
express moderate levels of mRNAD1 (Fig. 1C-E). Furthermore, 
the distribution of labeled cells among the cortical layers is 
not even. However, we are not able to find significant regional
differences in the D1 receptor gene expression along the 
rostocaudal axis of the cortex. In certain neocortical areas 
corresponding to the parietal (Fig. 1C), frontal (Fig. 1D, E), 
temporal and occipital cortex, most mRNAD1-positive neurons 
in the deeper layers show a moderate labeling, whereas in 
the more superficial layers II-III they display low mRNA
concentration. Conversely, the neocortical D2 receptor gene 
expression is extremely low to absent.
 In Fig. 1E, the intracellular localization of the mRNA and 
the morphological features of dopaminoceptive cells in the 
frontal cortex are depicted at a higher magnification.As shown,
most of the labeled neurons are medium-to-large-sized. The 
hybridization signals are located at the level of the neuronal 
cell bodies and confined to the cytoplasmic portion of the cells.
Furthermore, the labeling is usually limited to a thin rim of 
cytoplasm around an unlabeled nucleus. It is also possible to 
distinguish that the receptor gene products appear as clusters 
that can correspond to the endoplasmic reticulum. In contrast, 
we are not able to detect any labeled neuronal processes.
Basal ganglia and basal forebrain
As shown in Fig. 2, of the telencephalic structures examined, 
the highest expression of both D1-like and D2-like receptor 
messages is detected in the basal ganglia. In fact, D1 receptors 
are predominantly expressed in the dorsal and ventral striatum, 
D2 and D4 receptor subtypes are particularly abundant in 
the caudate-putamen complex, whereas the D3 subtype is 
restricted to the olfactory tubercle and ventral striatum (27). 
Also, D5 gene transcripts are expressed in most of the striatal 
neurons (75). With respect to projection areas, the dorsal 
striatum (or neostriatum) is an essential element of the classical 
concept of “basal ganglia”, and it is thought to include several 
loops which connect the cortex, lateral caudate-putamen, 
globus pallidus, subthalamic nucleus and substantia nigra. On 
the other hand, the ventral part has traditionally been related 
to the “limbic system”, including loops which connect other 
(“limbic”) cortical areas, the ventral striatum (especially the 
nucleus accumbens), the ventral pallidum, thalamus, and 
ventral tegmental area.
 In the striatum, DAergic nerve terminals are present as axonal 
varicosities, each forming about 1000 contacts on dendrites 
of the spiny neurons, which represent the vast majority of the 
striatal neurons (76). The DAergic input contacting primarily 
the neck of the spine is actually in a position to modulate the 
input from other neuronal afferents, for example, corticostratial 
nerve terminals, which contact the distal part of the spine (77). 
The main effect of DA here is to reduce spontaneous cell firing
or to decrease pharmacologically evoked activity (78,79). 
Previous studies in mammals (69,80) and birds (81) have found 
that DA acts principally through both D1 and D2 dopamine 
receptor subtypes, which are postsynaptically located and 
segregated to the direct and indirect striatal projection 
neurons, respectively (41,44,57,80,82). As published data 
confirm, the basal ganglia and basal forebrain are rich in D1
receptors. In particular, about half of the neurons throughout 
the striatum express D1 receptor gene (35,39). On the other 
hand, D2 receptors are expressed by the somata and dendrites 
of midbrain DA neurons in the substantia nigra and ventral 
tegmental area as well as by their axon terminals in their target 
region: the striatum and nucleus accumbens (83). There is still 
considerable controversy regarding whether or not D1 and D2 
receptor subtypes are expressed by distinct subpopulations of 
medium-sized spiny neurons in the striatum, which are known 
to be gamma-aminobutyric acid (GABA)ergic. To date, both 
the D2 and D4 receptors are found in these striatal neurons 
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Figure 2. Expression of DA receptor messages in the basal ganglia and basal forebrain of the rat. Localization of D1 gene 
transcripts in the caudate-putamen (CPu) by ISH using antisense (A) and sense (F) probes. D1 mRNA is present in most medium-
sized neurons. (B) Higher-power view of the boxed area in (A). The signal is confined to the neuronal perikarya of labeled
striatal neurons. (C) Small and a few large in size mRNAD2-expressing cells are also found in the striatum. A strong ISH signal is 
observed in the nucleus accumbens (D) and olfactory tubercle (E) as well. AcbC, accumbens nucleus, core; ec, external capsule; 
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(27). However, Gerfen et al (84) and Hersch et al (85) report 
that D1 and D2 receptors are expressed by different populations 
of striatal neurons: D1 receptors are mainly expressed by 
neurons in the ‘direct’ pathway, while D2 receptors - by 
neurons in the ‘indirect’ pathway. Conversely, Surmeier et al 
(86) have reported that D1- and D2-class receptors co-localize 
in approximately 50% of all medium-sized spiny projection 
neurons. Still, it remains unclear whether the D4 subtype is 
localized in D1-positive GABAergic neurons of the ‘indirect’ 
pathway. We have shown that the most intense signal is found 
in the caudate-putamen, where a large number of cells are 
strongly labeled with D1 antisense cRNA probe (Fig. 2A, B), 
but only a few small neurons are labeled with D2 cRNA probe 
(Fig. 2C). The mRNAD1-containing cells appear to be usually 
of medium size and morphologically homogenous. A strong 
signal is also obtained from neurons in the nucleus accumbens 
and olfactory tubercle (Fig 2D and E, respectively). The D3 
receptor gene is selectively expressed in the ventral striatal area 
(32) where neurons are shown to co-express D3 receptors with 
D1 or D2 receptors (87). In other striatal efferent neurons, D4 
and D5 receptors are also possibly co-expressed (88). Unlike a 
more homogenous distributional pattern throughout the extent 
of the caudate-putamen, the highest expression of mRNAD1 is 
detected within the rostral pole, mainly in the shell, and extends 
into the core of the nucleus accumbens (Fig. 2D). The labeled 
cells are similar in morphology to cells in the caudate-putamen. 
Ventrally in the olfactory tubercle, D1 receptor-labeled cells 
are scattered throughout the nucleus (Fig. 2E). In this area, 
a fraction of neurons (15%) may express both D1 and D2 
genes (82), thus suggesting that the olfactory tubercle could 
be regulated by DA differently from the dorsal striatum.
 In the caudate-putamen and nucleus accumbens, the D2 
receptor gene is mainly expressed by a population of small 
enkephalinergic neurons (89). Besides, a few large striatal 
neurons, identified as cholinergic, contain mRNAD2 and 
thus are under the direct influence of DA (89). It should be
emphasized that D2 receptors are expressed in both the shell 
and core of the nucleus accumbens (90). On the other hand, 
only scattered mRNAD2-containing cells are present in the 
globus pallidus. The lack of D1 signal in this region implicates 
that pallidal neurons do not mediate D1 responses. In fact, 
it has been reported that dopamine D2 receptor activation 
hyperpolarizes medium spiny striatopallidal neurons and 
inhibits GABA release (60,91).
 The classically defined nuclei that belong to the basal
forebrain include, in a rostral to caudal order, the medial 
septum, the nuclei of the vertical and horizontal limbs 
of the diagonal band of Broca, the ventral pallidum, the 
magnocellular preoptic area, the substantia innominata, and 
the magnocellular basal nucleus (92). The basal forebrain 
system is a source of multiple, neurochemically heterogeneous 
ascending and descending pathways with distinct cognitive and 
regulatory functions. Through direct and indirect projections 
via the reticular thalamic nucleus, basal forebrain neurons 
can influence the activity of neurons in the neocortex and
hippocampal formation and, thus, learning and memory 
(54). In the basal forebrain region, we have determined that 
mRNAD1 is detected in the islands of Calleja. The medial 
and lateral septal nuclei show a low mRNAD2 signal. In other 
subcortical limbic regions such as the bed nucleus of the 
stria terminalis, moderately labeled for D1 and D2 cells are 
scattered throughout the anterior and posterior subdivisions of 
this nucleus. In contrast, no D1 or D2 messages can be seen in 
the ventral pallidum, which is thought to be a ventral extension 
of the globus pallidus.
 Previous findings indicate that the basolateral amygdala
and the nucleus accumbens interact in influencing memory
consolidation. Interestingly, DA receptor messages are 
heterogeneously distributed throughout numerous component 
nuclei in the amygdaloid nuclear complex. For example, the 
strongest D1 receptor message is observed in the basal nuclear 
group as most of the neurons in the basomedial and basolateral 
nuclei show an intense signal. In addition, moderately labeled 
cell bodies are seen in the intercalated nuclei as well as in 
the cortex-amygdala transitional zone. Weak labeling is also 
apparent in the central nucleus. Conversely, the highest density 
of mRNAD2-expressing cells is revealed in the central nucleus. 
Other amygdala nuclei show very low expressional levels 
with weak signals and no detectable signal is evident in the 
periamygdaloid cortex.
Hippocampal formation
DAergic terminals exist also in the hippocampus (93). 
Hybridization with antisense probes reveals an intense labeling 
within all subfields of the hippocampal formation (Fig. 3),
whereas no signal is obtained in adjacent sections with the 
sense probes.
 Of particular interest in this regard are data showing that 
mRNAD1 is similarly abundant in the three fields of cornu 
Ammonis (CA) and in the granule cell layer of the dentate 
gyrus in both regio superior and inferior, although most of 
the labeled perikarya are concentrated in the more ventral 
aspects of the hippocampus. The most intense hybridization 
signal is seen in the principal cell layers. In CA, virtually all 
pyramidal cells from CA1 to CA3 are prominently labeled for 
D1 receptor (Fig. 3A), with the highest expression in CA2 (Fig. 
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Figure 3. Different D1 receptor gene expression patterns 
in the hippocampus. 
E
 DG
(B) Higher magnification of the CA2 field.
(C) Cells in the molecular and granular layers (arrows) 
of the dentate gyrus (DG) are mRNAD1-positive. 
(D)Fainter labeling is seen in the caudal dorsal 
hippocampus. 
(E) Methyl green-Pyronin Y staining of the hippocampus 
showing the presence of RNA in the tissue. 
LV, lateral ventricle; RSG, retrosplenial granular 
cortex. 
Bars = 170 µm in A, D, E, 30 µm in B and 100 µm in 
C. 
(A) Overview of the hippocampus demonstrating the 
prominent labeling of all pyramidal cells in CA1-3. Some 
labeled neurons are also observed in both the stratum 
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3B). However, in the stratum radiatum occasional mRNAD1-
positive neurons are also found. Sparse cells are visible in 
the stratum lacunosum-moleculare as well. The granule cells 
in the dentate gyrus are strongly labeled, particularly in the 
rostral part of the dorsal hippocampus (Fig. 3C), while the 
granule cell layer glia is not distinctly labeled. Interneurons 
in the hilar region also display a strong signal. In the ventral 
hippocampus and in the caudal part of the dorsal hippocampus, 
only faint mRNAD1 expression is observed in the subiculum 
proper, para- and pre- subiculum (Fig. 3D).
 The rat hippocampal formation, including its subicular 
region, shows no positive D2 hybridization signal. In the 
human hippocampus, however, major cell populations express 
D2 message (69), the D4 subtype being the predominant D2-
like receptor, particularly in the CA1 region (27).
MATCHING DISTRIBUTION OF DOPAMINE AND DOPAMINE 
RECEPTORS IN RAT FOREBRAIN
Perhaps the most interesting aspect of this review article deals 
with the issue of matching binding sites for specific ligands
with those of receptor subtype expression, and matching 
distribution of receptors with those of their projection fields
(94). In general, there is a large overlap in the expression of the 
receptor subtypes in the main forebrain territories innervated by 
the DAergic neurons (Table 1). As it can be seen, the regional 
and laminar distributional patterns of mRNAD1 and mRNAD2 in 
the rat forebrain are in qualitatively good agreement with the 
DA innervation and with the receptor binding site distribution. 
In rodents, the DAergic terminals are present in layers I and 
VI and restricted to the frontal lobe and particularly to the 
prefrontal, entorhinal and piriform cortices (66,67,95,96). Our 
previous (35) and present data show that these regions are also 
characterized by high expression of D1 receptors, and provide 
evidence that this DA receptor subtype mediates the action of 
DA in all DAergic projection fields. The overall distribution of 
mRNAD1 herein is largely consistent with that reported using 
D1 receptor autoradiography (20,22,23,31,97). In fact, in most 
regions of the adult rat brain the correspondence between the 
D1 receptor binding and mRNA overlaps. In certain forebrain 
regions, however, there are partial or complete mismatches. 
For example, D1 receptor binding sites have been identified
with no mRNAD1 observed or vice versa. One good example 
of such discordance is the hippocampal formation. Indeed, 
D1 receptor binding is found in moderate-to-low levels 
within the hippocampus, predominantly in the molecular cell 
layer (23,31,97). We have also obtained evidence in the rat 
for a mRNAD1 expression mainly within the pyramidal cell 
layer from CA1 to CA3 and in the dentate granule cell layer, 
consistent with previous data using immunohistochemical 
approach (25). Provided that the D1 message is translated 
into functional receptors, the most logical explanation for 
this discrepancy is that neurons in these layers are likely to 
synthesize D1 receptor in their cell bodies and transport them 
to the molecular layer of the dentate gyrus. On the contrary, 
Mansour et al (31) suggest an extra-hippocampal source of 
mRNAD1 as a possible explanation of this lack of mRNA/
protein correspondence. In accordance with this view, only 
few if any DA afferents originating from the A9-A10 area 
reach the hippocampal formation (93,98).
 Similarly, D2 receptor messages are also found both in 
major DA projection fields and in traditional regions associated
with DA-containing cell bodies, suggesting both postsynaptic 
and presynaptic autoreceptor localization (26,28,29,33). 
There is also a good anatomical correlation between the 
overall distribution of mRNAD2 and that revealed by earlier 
autoradiographic studies (20,21,23) in the striatum, especially 
in the caudate-putamen and nucleus accumbens. D2 mRNA 
transcripts are, however, absent in some cortical areas and 
in the hippocampus, where D2 receptor binding has been 
repeatedly shown. Another possible explanation for these 
conflicting mismatches is provided by the so-called volume
transmission theory (99). According to it, DA receptors are not 
necessarily confined to synapses but may be activated at far
distances by the transmitter which diffuses away from synaptic 
clefts via the extracellular fluid. In any case, the degree of
overlap implies a regional variation which may result in a 
regional heterogeneity in DA receptor functions.
DOPAMINE: A COMMON REGULATOR OF COGNITIVE, 
MEMORY AND LEARNING ASPECTS OF BEHAVIOR
It has been generally acknowledged that the projection fields
of DAergic terminals determine the functional significance of
DA neurons and may reflect their variability. Indeed, numerous
behavioral studies have indicated that DA has a multifaceted 
modulating effect on memory and other prefrontal cortical 
cognitive functions. Thus, the identification of forebrain
dopaminoceptive neurons as output pyramidal neurons or 
local circuit interneurons is important for understanding the 
physiological effects of DA in the cortex. Interaction of DA 
with its neuronal receptors in cortical circuits plays a major 
role in the regulation of excitability of pyramidal neurons by 
direct and indirect mechanisms (100). Further, subcortical 
structures, with their abundant DAergic innervation, may be 
of great importance for the cognitive functions.
 Until not long ago, the cellular action of DA was largely 
thought to be mediated via the activation of the D1 and D2 
69
Biomed Rev 16, 2005
Dopamine in cognition, learning and memory
subtypes of membrane receptors (reviewed in 101). From 
a functional point of view, the behavioral aspects of DA 
signaling have been attributed to interactions with D2 or D3 
receptors, the latter being most abundant in DAergic areas 
known to be associated with cognitive and emotional functions 
(32). Nowadays, it is assumed that the direct transmission of 
information to the cortical neurons is mediated by dopamine 
D1 receptors (62) located postsynaptically (102). Further, 
the inactivation of the D1 receptor has been shown to induce 
different behavioral alterations mainly concerning the limbic 
system. Hence, current knowledge of the localization of DA 
receptors indicates that the D1 and D2 receptors are present in 
efferent cortical populations at both synaptic and extrasynaptic 
sites where they are implicated in modulating a variety of 
important neuronal processes including those involved in 
excitotoxicity and plasticity (reviewed in 103). The selectivity 
of this location may have important functional consequences. 
For example, our own work has demonstrated that D1 and 
D2 receptors play a significant role in integrative aspects of
behavior involved in learning, memory and cognition, albeit 
D1 and D2 receptor-bearing neurons might subserve different 
functional modalities in cognition. It is worth noting that both 
D1-like and D2-like receptor subtypes are present in excitatory 
cortico-striatal and cortico-cortical projection neurons which 
generally contain excitatory amino acids, while only the D1 
isotype has been found in cortico-thalamic projection neurons 
(37). A recent study in rats and humans showed that in cortical 
neurons D4 receptor protein is associated with both pyramidal 
and nonpyramidal cells, whereas D2 and D3 receptors are 
mostly present in nonpyramidal interneurons (27). In addition, 
some inhibitory GABAergic interneurons in the deep cortical 
layers V-VI of the medial prefrontal cortex express D1 and D2 
receptor genes (60). This suggests that mesocortical DAergic 
inputs may directly modulate subpopulations of GABAergic 
interneurons and that their role in the functional organization 
of the prefrontal cortex involves synaptic inputs to both 
pyramidal and local circuits neurons. Further, DA facilitates 
glutamatergic transmission in rat prefrontal neurons (46). 
Taken together, these data further support the contention that 
DA may indeed have a complex action on cellular excitability 
in corical neurons, i.e. intitial suppression through D1 and D2 
receptors and subsequent enhancement through D1 receptors 
(104). These observations also emphasize that the localization 
of DA receptor subtypes in different categories of pyramidal 
neurons that project to the striatum and cortex as well as in 
various inhibitory interneurons is indicative of the influence of
DA on a vast repertoire of cortical circuits in the rat cerebral 
cortex.
 Although the presence of a prefrontal cortex in rodents 
in still questioned, it is generally accepted that this area 
is involved in different aspects of executive control (47). 
Through its complex role in cognition, memory and emotion, 
the mammalian prefrontal cortex is thought to contribute to the 
organization of adaptive behavioral actions. It is also of interest 
to note that the prefrontal cortex is involved in stimulus-
reinforcement associative learning as well (105). The medial 
prefrontal cortex is implicated in many cognitive functions, 
including working memory, temporal organization of behavior, 
and adaptation of behavioral strategies (105,106). In both rats 
and primates, the circuits that involve the prefrontal cortical 
areas are characterized by amygdaloid inputs. As a matter of 
fact, there is evidence that the medial prefrontal cortex and 
other regions such as the amygdala and nucleus accumbens 
are part of a distributed corticostriatal network mediating 
certain aspects of learning and expression of various motivated 
behaviors (107-109). The components of this network receive 
DAergic afferents from the ventral tegmental area (110,111). 
As a result, DA plays important roles in the function of the 
primate prefrontal cortex (62,63,106). On the other hand, the 
dorsolateral prefrontal cortex and posterior parietal cortices 
project mainly to adjacent, longitudinal domains of the 
anterior striatum, although there is also evidence for limited 
convergence of prefrontal and parietal cortical input within 
the striatum, particularly in the anteriormost part of the head 
of the caudate nucleus (112). These pathways are thought to 
constitute an anatomical circuit mediating spatial memory 
(113).
 Previous work has demonstrated that in addition to a general 
involvement of D1 receptors, there is also a critical level of 
D1 receptor activation required for optimal performance of a 
task (63). Thus, there is evidence suggesting that activation 
of dopamine D1 receptors in several discrete yet interacting 
brain regions is involved in both the acquisition of conditioned 
associations and the probable mediation of the ability of 
conditioned stimuli to control behavior (114).
 Extensive research has provided evidence that D2 receptors 
may play an important role in modulating synaptic plasticity 
and thus in cognitive and emotional processes performed by 
prefrontal circuits. In addition, recent studies indicate that the 
two isoforms of the D2 receptor may serve different synaptic 
functions: D2long receptors may act mostly as postsynaptic 
receptors while D2short receptors - as presynaptic autoreceptors 
(27,115). This hypothesis will undoubtedly contribute to 
the development of specific antagonists and agonists for
presynaptic versus postsynaptic D2 receptors which may be 
useful for the improvement of pharmacological treatment of 
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neuropsychiatric and movement disorders (116). 
 The basal ganglia are usually considered to be involved 
in the automatic selection of previously learned procedures 
contributing to behavioral adaptation. The nigrostriatal DA 
pathway is classically described as a crucial substrate related 
to motor activities and also known to express both D1 and 
D2 receptors. We have obtained evidence in the rat that the 
striatum is in a position to integrate information arising from 
the different associative cortical areas for motor planning. 
Paillard (117) emphasized the central position of the striatum 
in the integrative processes of behavior, particularly the 
evaluation of the context of behavior. In addition, it has been 
demonstrated that DA-related processing at the level of basal 
ganglia play a critical role in timing mechanisms (118-120).
 The expression of both D1 and D2 receptor gene transcripts 
in the basal ganglia suggests that DA plays an important role in 
the control of psychomotor behavior through different receptor 
subtypes. More significantly, the widespread distribution
of mRNAD1 throughout cortical, limbic, hypothalamic and 
thalamic regions (25,35) implies that in addition to such a 
role, D1 receptors may participate in the cognitive, affective 
and neuroendocrine effects of DAergic neurotransmission, 
and may be very important in mediating functions associated 
with memory, learning and cognitive processing.
 Alternatively, the D2 receptors in the brain have been 
implicated in a variety of neurological and psychiatric 
conditions, including Parkinson disease and schizophrenia. 
Regarding the cognitive aspects of behavior, however, 
dysfunctions of mesocorticolimbic DAergic neurons may 
contribute to schizophrenia in patients who can also show 
opposite changes in DA activity at cortical level (for a recent 
review see 121). Because DA depletion in the medial prefrontal 
cortex also reduces other forms of hyperactivity (122), it may 
be considered that the prefrontal DA cortical system is part of 
the neuronal network involved in behavioral inhibition, which 
may be deficient in schizophrenic patients. In this respect, if
schizophrenia in general could be related to a local alteration in 
cortical DAergic transmission, it is inferred that alterations in 
DA signaling could affect information processing. Moreover, 
aberrant levels of mRNAD1 in subregions of the frontal 
cortex may be involved in the altered functional activity 
of schizophrenia and affective disorders (69). Certainly, a 
decrease in D1 receptor density has been shown in the frontal 
cortex of schizophrenic patients to be correlated with the 
severity of negative cognitive signs, whereas no change has 
been seen in the striatum of these patients (123). Conversely, 
activation of the D2 receptor in the frontal cortex with specific
DA agonist has recently been shown to increase cognitive 
performance in humans (124). 
 As noted above, DA has also been implicated in the 
cognitive process of working memory (63). Working memory 
processes, which are also central for language understanding 
and comprehension and probably for intelligence and 
reasoning, are closely related to DAergic activity in the 
prefrontal cortex (62). Besides, experimental investigations 
with primates, using electrodes inserted into the cortex have 
shown that working memory is associated with activation of 
neurons in the prefrontal dorsolateral cortex (125). As indicated 
by pharmacological studies, inactivating the D1 receptor gene 
produces spatial learning deficits (126) which can be related
to the involvement of the D1 receptors in working memory 
processes in the prefrontal cortex (62) and to the presence of 
such receptors in hippocampus (127). The above cited studies 
suggests that D1 antagonists can selectively potentiate the 
‘memory fields’of prefrontal neurons which subserve working
memory. Similarly, our findings make it likely that cognitive
processes regulated via these regions involve D1 signaling.
 On the other hand, psychopharmacological research 
demonstrated that dopamine D2 agonists stimulate performance 
during the spatial working memory tasks whereas D2 
antagonists exhibit opposite effects. Hence, the D2 receptor 
agonist bromocriptine has a stimulating effect on cognitive 
function, namely visuospatial memory. Moreover, the 
antagonist sulpiride induced cognitive dysfunction in healthy 
subjects similar to the pattern seen in Parkinson’s disease, i.e. 
deficient spatial working memory, planning and attention shift
disturbance (128). Thus, the current view supports that D2 
receptor is likely to be a major type of DA receptors responsible 
for the modulation of D1/D2 equilibrium and so indirectly 
influences performance of working memory tasks (129).
CONCLUSION
It has become evident that DAergic neurons play a key role 
in controlling cognition, memory and learning. Importantly, 
it seems also reasonable to assume that the DAergic neurons 
are not integral parts of the neuronal networks involved in the 
execution of these functions but rather regulate such behavioral 
processes, as they do for motor and limbic aspects of behavior. 
Furthermore, changes in brain activity resulting in impairment 
or exacerbation of central DAergic transmission could probably 
result in pathologic effects on behavior, such as Alzheimer's 
disease or schizophrenia, and functional interaction of the two 
DA receptor subtypes may explain such clinical observations 
(reviewed in 130). Last but not least, gaining knowledge 
on forebrain DA receptors would provide new insights into 
the development of effective pharmacotherapy of cognitive 
dysfunction associated with several psychiatric disorders.
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